Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston gains FDA OK for bile duct stent:

This article was originally published in Clinica

Executive Summary

Boston Scientific has gained US FDA clearance to sell its Express biliary LD pre-mounted stent system for alleviating malignant biliary obstruction - a blockage in any ducts that carries bile from the liver to the gallbladder and on to the small intestine. The system incorporates Boston's Tandem Architecture stent design with Ultra-thin SDS balloon catheter technology. The low profile, balloon-expandable stent comes in a wide range of sizes, says the Natick, Massachusetts firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT068812

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel